This panel presents an overview of the current state of psychedelic research, which is undergoing a small renaissance.

Rick Doblin offers an overview of the current status of psychedelic research, Dr. Michael Mithoefer discusses his MAPS-sponsored study of MDMA-assisted psychotherapy in subjects with treatment-resistant posttraumatic stress disorder (PTSD), Dr. Charles Grob discusses his Heffter Research Institute-sponsored study of psilocybin-assisted psychotherapy in subjects with anxiety associated with advanced cancer, Dr. Francisco Moreno discusses his Heffter and MAPS-sponsored study of psilocybin in subjects with obsessive-compulsive disorder (OCD), Dr. John Halpern, Harvard Medical School, discusses his proposed study of MDMA-assisted psychotherapy in subjects with anxiety associated with advanced cancer, Sandra Karpetas discusses the use of ibogaine in patients with addictive disorders at the Iboga Therapy House in Vancouver, Canada, Randy Hencken and Jill Stammer discuss the use of ibogaine in patients with addictive disorders at the Ibogaine Association's clinic near San Diego in Rosarito, Mexico, and Valerie Mojeiko, MAPS staffer, discusses MAPS ibogaine outcome study.

This MAPS sponsored lecture, recorded at the 16th International Transpersonal Association Conference, June 12-18, Palm Springs California, is made available as a mp3 format file.